The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder (Q28296985)

https://api.crossref.org/works/10.1177%2F0269881104047283

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Increased serotonin platelet uptake after tianeptine administration in depressed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Tianeptine stimulates uptake of 5-hydroxytryptamine in vivo in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Hypercapneic ventilatory response in patients with panic disorder before and after alprazolam treatment and in pre- and postmenstrual women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Effects of tryptophan depletion on anxiety and on panic provoked by carbon dioxide challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Tianeptine and paroxetine in major depressive disorder, with a special focus on the anxious component in depression: an international, 6-week double-blind study dagger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Brief standard self-rating for phobic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Tianeptine, a selective enhancer of serotonin uptake in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Double-blind acute clonazepam vs. placebo in carbon dioxide-induced panic attacks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

35% CO2 challenge in panic and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Panic: course, complications and treatment of panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Effects of tryptophan depletion on carbon dioxide provoked panic in panic disorder patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

L-5-hydroxytryptophan induced increase in salivary cortisol in panic disorder patients and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

A 35% carbon dioxide challenge in simple phobias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Reliability of the 35% carbon dioxide panic provocation challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Tianeptine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depression and coexisting anxiety and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

A Rating Instrument For Anxiety Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881104047283

21 January 2018

Identifiers

DOI

10.1177/0269881104047283

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3666262

Fatcat ID

release_wdxk22mvx5epvjagvj5bbqxcfy

0 references

OpenCitations bibliographic resource ID

3666262

1 reference